GB0704394D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0704394D0 GB0704394D0 GBGB0704394.6A GB0704394A GB0704394D0 GB 0704394 D0 GB0704394 D0 GB 0704394D0 GB 0704394 A GB0704394 A GB 0704394A GB 0704394 D0 GB0704394 D0 GB 0704394D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0704394.6A GB0704394D0 (en) | 2007-03-07 | 2007-03-07 | Compounds |
PCT/GB2008/000761 WO2008107677A2 (en) | 2007-03-07 | 2008-03-06 | Thiadiazole and oxadiazole derivatives for the treatment of neurodegenerative disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0704394.6A GB0704394D0 (en) | 2007-03-07 | 2007-03-07 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0704394D0 true GB0704394D0 (en) | 2007-04-11 |
Family
ID=37966087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0704394.6A Ceased GB0704394D0 (en) | 2007-03-07 | 2007-03-07 | Compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0704394D0 (en) |
WO (1) | WO2008107677A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10303974A1 (en) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid β (1-42) oligomers, process for their preparation and their use |
PL1954718T3 (en) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies |
JP5486808B2 (en) | 2005-11-30 | 2014-05-07 | アッヴィ・インコーポレイテッド | Monoclonal antibody against amyloid beta protein and use thereof |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
EP2177521A1 (en) * | 2008-10-14 | 2010-04-21 | Almirall, S.A. | New 2-Amidothiadiazole Derivatives |
EP2305660A1 (en) * | 2009-09-25 | 2011-04-06 | Almirall, S.A. | New thiadiazole derivatives |
EP2343287A1 (en) * | 2009-12-10 | 2011-07-13 | Almirall, S.A. | New 2-aminothiadiazole derivatives |
CN104744591B (en) | 2010-04-15 | 2022-09-27 | Abbvie德国有限责任两合公司 | Amyloid beta binding proteins |
WO2012002527A1 (en) * | 2010-07-02 | 2012-01-05 | あすか製薬株式会社 | HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
CN105348387B (en) | 2010-08-14 | 2020-08-25 | Abbvie 公司 | Amyloid beta binding proteins |
MY174339A (en) | 2012-08-13 | 2020-04-09 | Novartis Ag | 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
US9040712B2 (en) | 2013-01-23 | 2015-05-26 | Novartis Ag | Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions |
ES2917979T3 (en) | 2013-07-31 | 2022-07-12 | Novartis Ag | 1,4-disubstituted pyridazine derivatives and their use to treat conditions related to SMN deficiency |
EP3275440B1 (en) * | 2015-03-25 | 2022-05-04 | National Center for Geriatrics and Gerontology | Novel oxadiazole derivative and pharmaceutical containing same |
CN105384736B (en) * | 2015-10-28 | 2018-11-02 | 南昌大学 | A kind of type Ⅳ collagen enzyme inhibitor and synthetic method |
CN108794427B (en) * | 2018-07-13 | 2022-07-29 | 江苏快达农化股份有限公司 | Synthetic method of 1,3, 4-thiadiazole derivative |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06001845A (en) * | 2003-08-21 | 2006-05-04 | Pfizer Prod Inc | Compounds for the treatment of neurodegenerative disorders. |
WO2005072731A1 (en) * | 2004-01-29 | 2005-08-11 | X-Ceptor Therapeutics, Inc. | 3-phenyl-n- ((1, 3, 4) thiadiazol-2-yl) -acrylamide derivatives and related compounds as modulators of estrogen-related receptors for the treatment of e.g. cancer, rheumatoid arthritis or neurological disorders |
US7232820B2 (en) * | 2004-04-01 | 2007-06-19 | Pfizer Inc | Thiadiazole-amine compounds for the treatment of neurodegenerative disorders |
GB0608386D0 (en) * | 2006-04-27 | 2006-06-07 | Senexis Ltd | Compounds |
-
2007
- 2007-03-07 GB GBGB0704394.6A patent/GB0704394D0/en not_active Ceased
-
2008
- 2008-03-06 WO PCT/GB2008/000761 patent/WO2008107677A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008107677A2 (en) | 2008-09-12 |
WO2008107677A3 (en) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0706793D0 (en) | Compounds | |
GB0704407D0 (en) | Compounds | |
GB0704394D0 (en) | Compounds | |
GB0705672D0 (en) | Compounds | |
GB0706173D0 (en) | Compounds | |
GB0707092D0 (en) | Compounds | |
GB0706188D0 (en) | Compounds | |
GB0706168D0 (en) | Compounds | |
GB0706165D0 (en) | Compounds | |
GB0707034D0 (en) | Compounds | |
GB0706174D0 (en) | Compounds | |
GB0706189D0 (en) | Compounds | |
GB0706187D0 (en) | Compounds | |
GB0706167D0 (en) | Compounds | |
GB0706190D0 (en) | Compounds | |
GB0706170D0 (en) | Compounds | |
GB0706164D0 (en) | Compounds | |
GB0704939D0 (en) | Compounds | |
GB0703756D0 (en) | Compounds | |
GB0701985D0 (en) | Compounds | |
GB0706023D0 (en) | Compounds | |
GB0702960D0 (en) | Compounds | |
GB0703906D0 (en) | Compounds | |
GB0701981D0 (en) | Compounds | |
GB0701977D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |